Just weeks after kick-starting its phase 1 test, Arch Oncology has gathered $50 million in financing to help see its immuno-oncology asset through the clinic.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,